WallStreetZenWallStreetZen

NASDAQ: NRXP
Nrx Pharmaceuticals Inc Stock Ownership - Who owns Nrx Pharmaceuticals?

Insider buying vs selling

Have Nrx Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Aaron GorovitzDirector2023-08-3035,000$0.32
$11.20kBuy
Chaim HurvitzDirector2023-08-3070,000$0.29
$20.09kBuy
Jonathan C. JavittChief Scientist2023-08-23100,000$0.33
$33.00kBuy
Jonathan C. JavittChief Scientist2023-08-22200,000$0.32
$64.40kBuy

1 of 1

NRXP insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NRXP insiders and whales buy or sell their stock.

NRXP Shareholders

What type of owners hold Nrx Pharmaceuticals Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Jonathan C. Javitt273.22%29,236,658$115.48MInsider
Daniel C. Javitt220.61%23,606,657$93.25MInsider
Chaim Hurvitz22.65%2,423,236$9.57MInsider
Brac Lending Group LLC20.83%2,228,435$8.80MInsider
Vanguard Group Inc13.46%1,440,045$5.69MInstitution
Polar Asset Management Partners Inc9.40%1,005,536$3.97MInsider
Advisorshares Investments LLC5.75%614,793$2.43MInstitution
Big Rock Partners Sponsor LLC4.85%519,315$2.05MInsider
Geode Capital Management LLC3.92%419,954$1.66MInstitution
Patrick John Flynn3.78%404,291$1.60MInsider

1 of 3

NRXP vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NRXP5.85%94.15%Net Buying
DARE6.75%25.30%
HCWB2.91%47.89%Net Buying
MTNB10.15%11.91%
ACXP7.88%15.18%Net Buying

Nrx Pharmaceuticals Stock Ownership FAQ

Who owns Nrx Pharmaceuticals?

Nrx Pharmaceuticals (NASDAQ: NRXP) is owned by 34.89% institutional shareholders, 561.21% Nrx Pharmaceuticals insiders, and 0.00% retail investors. Jonathan C. Javitt is the largest individual Nrx Pharmaceuticals shareholder, owning 29.24M shares representing 273.22% of the company. Jonathan C. Javitt's Nrx Pharmaceuticals shares are currently valued at $111.98M.

If you're new to stock investing, here's how to buy Nrx Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.